Anondita Medicare IPO subscription started on Friday, August 22, 2025, and will close on August 26, 2025, as per the schedule. The price band is set at âč137 to âč145 per share with a face value of âč10.
Anondita Medicare IPO Subscription Status
Anondita Medicare IPO subscribed over 3.40x on its first day till 5.00 PM on August 22, 2025.
- Anondita Medicare IPO subscription QIB investors’ portion is 0.11 times, while NII subscribed 1.93 times, and RII investors subscribed 5.92 times.
- The company has received bids for 1,08,01,000 shares against 31,73,000 shares on offer on the first day of subscription.
- Anondita Medicare IPO subscribed over 3.40x on its day 1.
About Anondita Medicare Company
Anondita Medicare Limited, incorporated in March 2024, is one of the growing companies involved in the manufacturing of flavored male condoms under its main brand, âCOBRA.â The company has an annual production of 562 million condoms. Its manufacturing units are situated in Noida, Uttar Pradesh. Anondita Medicare exports its products to Southeast Asia, Africa, and the Middle East. Anondita Medicare Limited is involved in working with global health groups, NGOs, and governments in order to promote family planning and public health. The company also holds a strong distribution network that delivers its products on time to different markets.
Anondita Medicare partners with wholesalers, retailers, and e-commerce platforms with the aim of making products easily available to everyone. The company includes 280 employees as of July 31, 2025. Moreover, the company also partners with government health programs to supply essential medical products.
Anondita Medicare Financial Report
The company reported revenue of âč77.13 crores in 2025 against âč46.56 crores in 2024. The company reported a profit of âč16.42 crores in 2025 against a profit of âč3.84 crores in 2024.
Anondita Medicare IPO GMP
Anondita Medicare IPO GMP was âč58 as of Friday, August 22, 2025. That indicates the IPO is trading at âč203 with a âč58 premium in the grey market against the issue price of âč145.